diacerein has been researched along with Psoriasis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bao, L; Chan, LS; Many, B; Mohan, GC; Zhang, H | 1 |
| Ahad, A; Aqil, M; Imam, SS; Moghddam, SR; Sultana, Y | 1 |
| Berdah, L; Dougados, M; Gossec, L; Kalyoncu, U; Lequesne, M; Mazières, B; Nguyen, M | 1 |
3 other study(ies) available for diacerein and Psoriasis
| Article | Year |
|---|---|
Diacerein inhibits the pro-atherogenic & pro-inflammatory effects of IL-1 on human keratinocytes & endothelial cells.
Topics: Anthraquinones; Anti-Inflammatory Agents; Atherosclerosis; Cells, Cultured; Endothelial Cells; Enzyme-Linked Immunosorbent Assay; Humans; Inflammation; Interleukin-1alpha; Interleukin-1beta; Keratinocytes; Oligonucleotide Array Sequence Analysis; Osteoarthritis; Psoriasis; Real-Time Polymerase Chain Reaction | 2017 |
Formulation and optimization of niosomes for topical diacerein delivery using 3-factor, 3-level Box-Behnken design for the management of psoriasis.
Topics: Administration, Topical; Animals; Anthraquinones; Chemistry, Pharmaceutical; Drug Delivery Systems; Drug Liberation; Kinetics; Liposomes; Microscopy, Confocal; Particle Size; Permeability; Psoriasis; Rats; Skin | 2016 |
Self-reported prevalence of psoriasis and evaluation of the impact on the natural history of hip osteoarthritis: results of a 10 years follow-up study of 507 patients (ECHODIAH study).
Topics: Aged; Anthraquinones; Anti-Inflammatory Agents; Arthralgia; Cohort Studies; Disability Evaluation; Disease Progression; Female; Follow-Up Studies; Genetic Linkage; Genetic Predisposition to Disease; Health Surveys; Humans; Interviews as Topic; Male; Middle Aged; Osteoarthritis, Hip; Prevalence; Psoriasis; Self Concept | 2009 |